Skip to main content
TipRanks
Go Ultimate75% OFF

Dara Azar Profile - Stifel Nicolaus Analyst

4 Followers

Dara Azar's Stock Coverage

WHWK
Whitehawk Therapeutics
Nov 10, 2026BUYReiterated$9.002Ratings0%-16.70%
IMNM
Immunome
Nov 10, 2026HOLDAssigned$23.003Ratings――
SMMT
Summit Therapeutics
Nov 05, 2026BUYReiterated$37.009Ratings67%+4.38%
ELVN
Enliven Therapeutics
Nov 05, 2026BUYReiterated$82.005Ratings75%+7.63%
INBX
Inhibrx Biosciences Inc
Oct 29, 2026BUYReiterated$325.009Ratings20%-2.98%

Disclaimer: TipRanks collects analysts’ ratings and price targets by scanning publicly available reports on financial websites and by receiving reports from analysts, firms, or customers. The information and statistics displayed might not be accurate, complete, or up-to-date. The analyst ratings provided are the sole responsibility of the source publication. TipRanks holds no liability over the analysts' information, price targets, ratings, or opinions expressed. See how TipRanks ranks experts and calculates performance.

Send Us Reports
If you receive reports that you think we are missing, we will thank you with a free Ultimate upgrade!
Learn More >

Dara Azar activity FAQ

What is the performance of Dara Azar's recommendations?
The percentage of profitable recommendations made by Dara Azar is 50.00%, and the average return per transaction is 1.50%.
What stocks does Dara Azar cover?
Dara Azar mostly covers Immunome, Whitehawk Therapeutics, Enliven Therapeutics stocks.
What was Dara Azar's most profitable rating?
Dara Azar’s most profitable rating was a buy on Enliven Therapeutics stock on Jun 09, 2026. The return on the trade was 36.80%.
Where can I see a list of stock analyst ratings?
You can see a list of daily stock analyst ratings here.
What are the most recommended stocks by analysts?
You can see a list of the most recommended stocks by analysts here